Filters: Tags: epidermal growth factor (X)21 results (82ms)
c-erbB activation in avian leukosis virus-induced erythroblastosis: Multiple epidermal growth factor receptor mRNAs are generated by alternative RNA processing.
Cross-reaction between antibodies raised against the last 20 C-terminal amino acids of BRCA 1 (C-20) and human EGF and EGF-R in MCF 10a human mammary epithelial cell line
Expression cloning of human EGF receptor complementary DNA: Gene amplification and three related messenger RNA products in A431 cells.
Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and V-erbB protein.
Activation of c-erbB in avian leukosis virus-induced erythroblastosis leads to the expression of a truncated EGF receptor kinase.
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.
Differences in sequences encoding the carboxyl-terminal domain of the epidermal growth factor receptor correlate with differences in the disease potential of viral erbB genes.
Characterization of site-specific antibodies to the erbB gene product and EGF receptor: Inhibition of tyrosine kinase activity.
Synthesis of epidermal growth factor (EGF) receptor in vitro using SP6 RNA polymerase-transcribed template mRNA.
Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.
Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways
Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types
Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells.